255 related articles for article (PubMed ID: 15864270)
1. Elucidating mechanisms of drug-induced toxicity.
Liebler DC; Guengerich FP
Nat Rev Drug Discov; 2005 May; 4(5):410-20. PubMed ID: 15864270
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Combinatorial pharmacogenetics.
Wilke RA; Reif DM; Moore JH
Nat Rev Drug Discov; 2005 Nov; 4(11):911-8. PubMed ID: 16264434
[TBL] [Abstract][Full Text] [Related]
4. In silico toxicology for the pharmaceutical sciences.
Valerio LG
Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
[TBL] [Abstract][Full Text] [Related]
5. Integrating metabolism and toxicity in multi-organ systems.
Madden S; Bach PH
Curr Opin Drug Discov Devel; 2001 Jan; 4(1):66-72. PubMed ID: 11727325
[TBL] [Abstract][Full Text] [Related]
6. Perspectives on epigenetics and its relevance to adverse drug reactions.
Kacevska M; Ivanov M; Ingelman-Sundberg M
Clin Pharmacol Ther; 2011 Jun; 89(6):902-7. PubMed ID: 21508940
[No Abstract] [Full Text] [Related]
7. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
Gómez-Lechón MJ; Castell JV; Donato MT
Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
[TBL] [Abstract][Full Text] [Related]
8. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
[TBL] [Abstract][Full Text] [Related]
9. The biochemistry of drug metabolism--an introduction: part 5. Metabolism and bioactivity.
Testa B; Krämer SD
Chem Biodivers; 2009 May; 6(5):591-684. PubMed ID: 19479846
[TBL] [Abstract][Full Text] [Related]
10. Screening for reactive intermediates and toxicity assessment in drug discovery.
Caldwell GW; Yan Z
Curr Opin Drug Discov Devel; 2006 Jan; 9(1):47-60. PubMed ID: 16445117
[TBL] [Abstract][Full Text] [Related]
11. Understanding mechanisms of toxicity: insights from drug discovery research.
Houck KA; Kavlock RJ
Toxicol Appl Pharmacol; 2008 Mar; 227(2):163-78. PubMed ID: 18063003
[TBL] [Abstract][Full Text] [Related]
12. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
Fischer HP
Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773
[TBL] [Abstract][Full Text] [Related]
13. Development of an approach for ab initio estimation of compound-induced liver injury based on global gene transcriptional profiles.
Dai X; He YD; Dai H; Lum PY; Roberts CJ; Waring JF; Ulrich RG
Genome Inform; 2006; 17(2):77-88. PubMed ID: 17503381
[TBL] [Abstract][Full Text] [Related]
14. The future of drug safety testing: expanding the view and narrowing the focus.
Stevens JL; Baker TK
Drug Discov Today; 2009 Feb; 14(3-4):162-7. PubMed ID: 19100337
[TBL] [Abstract][Full Text] [Related]
15. A combined approach to drug metabolism and toxicity assessment.
Ekins S; Andreyev S; Ryabov A; Kirillov E; Rakhmatulin EA; Sorokina S; Bugrim A; Nikolskaya T
Drug Metab Dispos; 2006 Mar; 34(3):495-503. PubMed ID: 16381662
[TBL] [Abstract][Full Text] [Related]
16. High-throughput human metabolism and toxicity analysis.
Lee MY; Dordick JS
Curr Opin Biotechnol; 2006 Dec; 17(6):619-27. PubMed ID: 17046235
[TBL] [Abstract][Full Text] [Related]
17. Idiosyncratic toxicity: mechanistic insights gained from analysis of prior compounds.
Waring JF; Anderson MG
Curr Opin Drug Discov Devel; 2005 Jan; 8(1):59-65. PubMed ID: 15679173
[TBL] [Abstract][Full Text] [Related]
18. Animal models of idiosyncratic drug reactions.
Shenton JM; Chen J; Uetrecht JP
Chem Biol Interact; 2004 Nov; 150(1):53-70. PubMed ID: 15522261
[TBL] [Abstract][Full Text] [Related]
19. The challenge of predicting drug toxicity in silico.
Vedani A; Dobler M; Lill MA
Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):195-208. PubMed ID: 16930291
[TBL] [Abstract][Full Text] [Related]
20. A regulatory perspective on issues and approaches in characterizing human metabolites.
Davis-Bruno KL; Atrakchi A
Chem Res Toxicol; 2006 Dec; 19(12):1561-3. PubMed ID: 17173368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
